Literature DB >> 18815219

p53 regulates renal expression of HIF-1{alpha} and pVHL under physiological conditions and after ischemia-reperfusion injury.

Timothy A Sutton1, Jared Wilkinson, Henry E Mang, Nicole L Knipe, Zoya Plotkin, Maya Hosein, Katelyn Zak, Jeremy Wittenborn, Pierre C Dagher.   

Abstract

Ischemia-reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) and is characterized by widespread tubular and microvascular damage. The tumor suppressor p53 is upregulated after IRI and contributes to renal injury in part by promoting apoptosis. Acute, short-term inhibition of p53 with pifithrin-alpha conveys significant protection after IRI. The hypoxia-inducible factor-1 (HIF-1) pathway is also activated after IRI and has opposing effects to those promoted by p53. The balance between the HIF-1 and p53 responses can determine the outcome of IRI. In this manuscript, we investigate whether p53 regulates the HIF-1 pathway in a rodent model of IRI. HIF-1alpha is principally expressed in the collecting tubules (CT) and thick ascending limbs (TAL) under physiological conditions. However, inhibition of p53 with pifithrin-alpha increases the faint expression of HIF-1alpha in proximal tubules (PT) under physiological conditions. Twenty-four hours after IRI, HIF-1alpha expression is decreased in both CT and TAL. HIF-1alpha expression in the PT is not significantly altered after IRI. Acute inhibition of p53 significantly increases HIF-1alpha expression in the PT after IRI. Additionally, pifithrin-alpha prevents the IRI-induced decrease in HIF-1alpha in the CT and TAL. Parallel changes are observed in the HIF-1alpha transcriptive target, carbonic anhydrase-9. Finally, inhibition of p53 prevents the dramatic changes in Von Hippel-Lindau protein morphology and expression after IRI. We conclude that activation of p53 after IRI mitigates the concomitant activation of the protective HIF-1 pathway. Modulating the interactions between the p53 and HIF-1 pathway can provide novel options in the treatment of AKI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815219      PMCID: PMC2604829          DOI: 10.1152/ajprenal.90304.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  50 in total

Review 1.  Recent advances in the pathophysiology of ischemic acute renal failure.

Authors:  Joseph V Bonventre; Joel M Weinberg
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

2.  Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group.

Authors:  F Liaño; J Pascual
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

Review 3.  Ischemic acute renal failure: an inflammatory disease?

Authors:  Joseph V Bonventre; Anna Zuk
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

4.  Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation.

Authors:  Patrick J M Murphy; Mario D Galigniana; Yoshihiro Morishima; Jennifer M Harrell; Roland P S Kwok; Mats Ljungman; William B Pratt
Journal:  J Biol Chem       Date:  2004-05-15       Impact factor: 5.157

5.  Spectrum of acute renal failure in the intensive care unit: the PICARD experience.

Authors:  Ravindra L Mehta; Maria T Pascual; Sharon Soroko; Brandon R Savage; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Glenn M Chertow
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

6.  Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury.

Authors:  K J Kelly; T A Sutton; N Weathered; N Ray; E J Caldwell; Z Plotkin; P C Dagher
Journal:  Am J Physiol Renal Physiol       Date:  2004-06-01

7.  Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha.

Authors:  Hai-Tao Yuan; Xiao-Zhong Li; Jolanta E Pitera; David A Long; Adrian S Woolf
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).

Authors:  Tobias Schmid; Jie Zhou; Roman Köhl; Bernhard Brüne
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

9.  Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.

Authors:  Sandra Turcotte; Richard R Desrosiers; Richard Beliveau
Journal:  Am J Physiol Renal Physiol       Date:  2003-10-28

10.  P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor.

Authors:  K J Kelly; Zoya Plotkin; Stacey L Vulgamott; Pierre C Dagher
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  19 in total

1.  Impaired wound healing in hypoxic renal tubular cells: roles of hypoxia-inducible factor-1 and glycogen synthase kinase 3β/β-catenin signaling.

Authors:  Jianping Peng; Ganesan Ramesh; Lin Sun; Zheng Dong
Journal:  J Pharmacol Exp Ther       Date:  2011-10-18       Impact factor: 4.030

2.  Approaches to the Management of Acute Kidney Injury in Children.

Authors:  Rajit K Basu; Derek S Wheeler
Journal:  Recent Pat Biomark       Date:  2011

Review 3.  Pathologies associated with the p53 response.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-07       Impact factor: 10.005

Review 4.  Novel roles for mucin 1 in the kidney.

Authors:  Mohammad M Al-Bataineh; Timothy A Sutton; Rebecca P Hughey
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-09       Impact factor: 2.894

5.  HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury.

Authors:  Rena Feinman; Edwin A Deitch; Anthony C Watkins; Billy Abungu; Iriana Colorado; Kolenkode B Kannan; Sharvil U Sheth; Francis J Caputo; Qi Lu; Madhuri Ramanathan; Shirhan Attan; Chirag D Badami; Danielle Doucet; Dimitrios Barlos; Marta Bosch-Marce; Gregg L Semenza; Da-Zhong Xu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-05       Impact factor: 4.052

6.  Muc1 is protective during kidney ischemia-reperfusion injury.

Authors:  Núria M Pastor-Soler; Timothy A Sutton; Henry E Mang; Carol L Kinlough; Sandra J Gendler; Cathy S Madsen; Sheldon I Bastacky; Jacqueline Ho; Mohammad M Al-Bataineh; Kenneth R Hallows; Sucha Singh; Satdarshan P Monga; Hanako Kobayashi; Volker H Haase; Rebecca P Hughey
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-29

7.  The p53 inhibitor pifithrin-α can stimulate fibrosis in a rat model of ischemic acute kidney injury.

Authors:  Pierre C Dagher; Erik M Mai; Takashi Hato; So-Young Lee; Melissa D Anderson; Stephanie C Karozos; Henry E Mang; Nicole L Knipe; Zoya Plotkin; Timothy A Sutton
Journal:  Am J Physiol Renal Physiol       Date:  2011-11-02

Review 8.  Pathogenesis of acute kidney injury: foundation for clinical practice.

Authors:  Gilbert R Kinsey; Mark D Okusa
Journal:  Am J Kidney Dis       Date:  2011-05-06       Impact factor: 8.860

9.  TIGAR regulates glycolysis in ischemic kidney proximal tubules.

Authors:  Jinu Kim; Kishor Devalaraja-Narashimha; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-10

10.  Novel application of complementary imaging techniques to examine in vivo glucose metabolism in the kidney.

Authors:  Takashi Hato; Allon N Friedman; Henry Mang; Zoya Plotkin; Shataakshi Dube; Gary D Hutchins; Paul R Territo; Brian P McCarthy; Amanda A Riley; Kumar Pichumani; Craig R Malloy; Robert A Harris; Pierre C Dagher; Timothy A Sutton
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.